Actuate Therapeutics (ACTU) Financials

Balance sheets

Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023

Total Assets

$14.3 M(+724.1%)$1.7 M(-35.9%)$2.7 M(-9.9%)$3.0 M---

Current Assets

$14.3 M(+2494.7%)$549.7 K(-74.9%)$2.2 M(-27.0%)$3.0 M---

Non Current Assets

$0.0(-100.0%)$1.2 M(+131.4%)$510.5 K(+100.0%)$0.0---

Total Liabilities

$8.9 M(-92.3%)$116.0 M(+5.0%)$110.5 M(+7.7%)$102.6 M---

Current Liabilities

$8.5 M(-57.7%)$20.1 M(+36.2%)$14.7 M(+112.9%)$6.9 M---

Long Term Liabilities

$406.7 K(-99.6%)$95.9 M(+0.2%)$95.7 M(+0.0%)$95.7 M---

Shareholders Equity

$5.4 M(+104.7%)-$114.3 M(-6.0%)-$107.8 M(-8.2%)-$99.6 M---

Book Value

$5.4 M(+104.7%)-$114.3 M(-6.0%)-$107.8 M(-8.2%)-$99.6 M---

Working Capital

$5.8 M(+129.5%)-$19.5 M(-55.6%)-$12.5 M(-219.6%)-$3.9 M---

Cash And Cash Equivalents

$13.5 M(+3745.2%)$351.7 K(-83.0%)$2.1 M(-30.1%)$3.0 M---

Accounts Payable

$2.3 M(-60.5%)$5.9 M(+49.0%)$4.0 M(+15.6%)$3.4 M---

Accounts Receivable

-------

Short Term Debt

-$6.9 M(+38.0%)$5.0 M----

Long Term Debt

-------

Total Debt

$0.0(-100.0%)$6.9 M(+38.0%)$5.0 M(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(+100.0%)-0.1(-20.0%)-0.1(-100.0%)0.0---

Current Ratio

1.7(+5500.0%)0.0(-80.0%)0.1(-65.1%)0.4---

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$125.9 M(-5.0%)-$120.0 M(-5.8%)-$113.4 M(-7.9%)-$105.1 M---

PB Ratio

28.7------

Income statements

Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023

EPS

-$0.6(-59.9%)-$0.3(+36.3%)-$0.5(-35.6%)-$0.4(+2.7%)-$0.4(-14.8%)-$0.4(-4.8%)-$0.3

TTM EPS

-$1.8(-8.3%)-$1.7(+0.8%)-$1.7(-13.3%)-$1.5(-36.0%)-$1.1(-58.7%)-$0.7(-104.8%)-$0.3

Revenue

-------

TTM Revenue

-------

Total Expenses

$5.4 M(-0.8%)$5.4 M(-30.1%)$7.8 M(+2.1%)$7.6 M(+17.6%)$6.5 M(+16.0%)$5.6 M(+5.4%)$5.3 M

Operating Expenses

$5.4 M(-0.8%)$5.4 M(-30.1%)$7.8 M(+2.1%)$7.6 M(+17.6%)$6.5 M(+16.0%)$5.6 M(+5.4%)$5.3 M

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$5.4 M(+0.8%)-$5.4 M(+30.1%)-$7.8 M(-2.1%)-$7.6 M(-17.6%)-$6.5 M(-16.0%)-$5.6 M(-5.4%)-$5.3 M

TTM Operating Profit

-$26.2 M(+4.0%)-$27.3 M(+0.5%)-$27.4 M(-9.9%)-$25.0 M(-43.9%)-$17.4 M(-59.5%)-$10.9 M(-105.4%)-$5.3 M

Operating Margin

-------

Net Income

-$6.0 M(+9.2%)-$6.6 M(+20.8%)-$8.3 M(-9.0%)-$7.6 M(-20.1%)-$6.3 M(-14.7%)-$5.5 M(-4.8%)-$5.3 M

TTM Net Income

-$28.5 M(+1.3%)-$28.8 M(-3.8%)-$27.8 M(-12.2%)-$24.7 M(-44.4%)-$17.1 M(-58.7%)-$10.8 M(-104.8%)-$5.3 M

Net Margin

-------

EBIT

-$6.0 M(+9.1%)-$6.6 M(+20.8%)-$8.3 M(-9.0%)-$7.6 M(-20.1%)-$6.3 M(-14.7%)-$5.5 M(-5.3%)-$5.2 M

TTM EBIT

-$28.4 M(+1.3%)-$28.8 M(-3.8%)-$27.8 M(-12.3%)-$24.7 M(-44.5%)-$17.1 M(-58.9%)-$10.8 M(-105.3%)-$5.2 M

EBITDA

-$6.0 M(+9.1%)-$6.6 M(+20.8%)-$8.3 M(-9.0%)-$7.6 M(-20.1%)-$6.3 M(-14.7%)-$5.5 M(-5.3%)-$5.2 M

TTM EBITDA

-$28.4 M(+1.3%)-$28.8 M(-3.8%)-$27.8 M(-12.3%)-$24.7 M(-44.5%)-$17.1 M(-58.9%)-$10.8 M(-105.3%)-$5.2 M

Selling, General & Administrative Expenses

$1.6 M(+53.9%)$1.1 M(+16.4%)$912.8 K(-5.8%)$969.4 K(+35.7%)$714.2 K(-11.5%)$807.2 K(+4.2%)$774.8 K

TTM SGA

$4.6 M(+25.2%)$3.7 M(+7.5%)$3.4 M(+4.2%)$3.3 M(+42.2%)$2.3 M(+45.1%)$1.6 M(+104.2%)$774.8 K

Depreciation And Amortization

-------

TTM D&A

-------

Interest Expense

$3500.0(-31.4%)$5100.0(0%)$5100.0(0%)$5100.0(0%)$5100.0(0%)$5100.0(-82.1%)$28.5 K

TTM Interest Expense

$18.8 K(-7.8%)$20.4 K(0%)$20.4 K(-53.4%)$43.8 K(+13.2%)$38.7 K(+15.2%)$33.6 K(+17.9%)$28.5 K

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023

Cash From Operations

-$9.1 M(-242.2%)-$2.7 M(+49.0%)-$5.2 M(+4.8%)-$5.5 M(+2.2%)-$5.6 M(-10.2%)-$5.1 M(+4.5%)-$5.4 M

TTM CFO

-$22.6 M(-18.4%)-$19.1 M(+11.3%)-$21.5 M(+0.5%)-$21.6 M(-34.2%)-$16.1 M(-53.8%)-$10.5 M(-95.5%)-$5.4 M

Cash From Investing

-------

TTM CFI

-------

Cash From Financing

$22.3 M(+2232.4%)$957.0 K(-78.0%)$4.4 M(+100.0%)$0.0(0%)$0.0(-100.0%)$1.7 M(-32.2%)$2.5 M

TTM CFF

$27.6 M(+420.0%)$5.3 M(-11.8%)$6.0 M(+45.8%)$4.1 M(0%)$4.1 M(0%)$4.1 M(+67.8%)$2.5 M

Free Cash Flow

-$9.1 M(-242.2%)-$2.7 M(+49.0%)-$5.2 M(+4.8%)-$5.5 M(+2.2%)-$5.6 M(-10.2%)-$5.1 M(+4.5%)-$5.4 M

TTM FCF

-$22.6 M(-18.4%)-$19.1 M(+11.3%)-$21.5 M(+0.5%)-$21.6 M(-34.2%)-$16.1 M(-53.8%)-$10.5 M(-95.5%)-$5.4 M

CAPEX

-------

TTM CAPEX

-------

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------